TNXP Deferred Revenue
Tonix Pharmaceuticals Holding Corp · Deferred Revenue
TNXP Deferred Revenue
Latest reported$3.43Mperiod ending
TNXP FY Deferred Revenue ($0.00 → $3.43M)
Annual deferred revenue
High-resolution chart · PNG
TNXP deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 3,425,000 | |
| 1,816,000 | |
| 2,980,000 | |
| 3,273,000 | |
| 2,832,000 | |
| 2,169,000 | |
| 704,000 | |
| 475,000 | |
| 519,000 | |
| 504,000 | |
| 2,246,000 | |
| 0 | |
| 0 | |
| 0 | |
| 48,535 | |
| 0 | |
| 0 | |
| 0 |